HER2 becomes significant in cancer when it is overexpressed. This overexpression is often due to a gene mutation or amplification, leading to the production of an excessive number of HER2 proteins. This can cause cells to grow and divide more quickly than normal, contributing to tumor formation and progression. HER2-positive cancers are particularly aggressive and are known to have a poorer prognosis.
